Biggest News Aggregation in the World
📰 Tse Aps News

Page 2 - Tse Aps News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tse Aps. Real-time updates on events, politics, business and more.

Aptose Biosciences Inc. Expected to Earn FY2022 Earnings of ($0.60) Per Share (TSE:APS)

Aptose Biosciences Inc. (TSE:APS – Get Rating) (NASDAQ:APTO) – Cantor Fitzgerald issued their FY2022 earnings estimates for Aptose Biosciences in a note issued to investors on Wednesday, September 21st. Cantor Fitzgerald analyst L. Watsek forecasts that the biotechnology company will post earnings per share of ($0.60) for the year. Cantor Fitzgerald currently has a “Overweight” […]
Aptose Bioscience Aptose Biosciences Aptose Biosciences Company Profile Cantor Fitzgerald Aptose Biosciences Inc Get Rating

Jonestrading Reiterates Buy Rating for Aptose Biosciences (TSE:APS)

Aptose Biosciences (TSE:APS – Get Rating) (NASDAQ:APTO)‘s stock had its “buy” rating restated by research analysts at Jonestrading in a research report issued on Friday, TipRanks reports. They currently have a C$5.00 target price on the biotechnology company’s stock. Jonestrading’s target price points to a potential upside of 306.50% from the stock’s previous close. A […]
Aptose Biosciences Cantor Fitzgerald Aptose Biosciences Inc Aptose Biosciences Company Profile Get Rating Get Rating Biosciences Company Profile

Aptose Biosciences (APS) Set to Announce Earnings on Tuesday

Aptose Biosciences (TSE:APS – Get Rating) (NASDAQ:APTO) is set to release its earnings data after the market closes on Tuesday, March 22nd. Analysts expect Aptose Biosciences to post earnings of C($0.23) per share for the quarter. APS opened at C$1.33 on Tuesday. The stock has a 50-day moving average price of C$1.56 and a 200-day […]
Aptose Biosciences Cantor Fitzgerald Aptose Biosciences Inc Aptose Biosciences Company Profile Get Rating Get Rating Biosciences Company Profile

Aptose Biosciences (TSE:APS) Hits New 52-Week Low at $1.30

Aptose Biosciences Inc. (TSE:APS – Get Rating) (NASDAQ:APTO) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$1.30 and last traded at C$1.31, with a volume of 49495 shares. The stock had previously closed at C$1.40. Several research firms have recently issued reports on APS. Cantor Fitzgerald […]
Aptose Biosciences Cantor Fitzgerald Aptose Biosciences Inc Get Rating Biosciences Inc Tse Aps

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science